News & Press Releases

2021

December 16

Test Press Release - New Columns Feature

Edinburgh, Scotland –Sed gravida efficitur urna et sodales. Sed pretium ex consectetur purus sagittis consectetur. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Nullam cursus, turpis ac tincidunt scelerisque, turpis felis iaculis urna, ac rutrum enim sem sed nibh. Morbi vehicula dignissim tortor, in suscipit lacus laoreet …

Read More
October 14

TC BioPharm Announces Launch of COVID-19 Phase I/II Human Trial

EDINBURGH, Scotland –TC BioPharm LTD, a clinical stage biotechnology company developing an allogeneic gamma-delta T cell platform, today announces launch of a Phase I/II trial in COVID-19 infected patients in the UK. The Company will utilize ImmuniStim®, its proprietary allogeneic gamma-delta T cell product in early-diagnosis COVID-19 patients. With recruitment initially commencing …

Read More
September 30

TC BioPharm Announces Dr. Sebastian Wanless as Senior Clinical Director

Glasgow, UK –About TC BioPharm, Ltd. TC BioPharm is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer and viral infections with human efficacy data in acute myeloid leukemia. Gamma-delta T cells are naturally occurring immune cells that embody properties …

Read More
August 13

TC BioPharm Named as Top 5 Female Powered Companies in United Kingdom

Glasgow, UK –TC BioPharm has grown substantially since being founded by Angela Scott in 2014, under her leadership as COO the Company has seen valuation increase in every investment round, culminating with a recent capitalization of the Company over £100,000,000. “This ranking is unexpected but very welcome,” commented Ms. Scott, “and I’d …

Read More

News & Press Releases

2021

Test Press Release - New Columns Feature

TC BioPharm Announces Launch of COVID-19 Phase I/II Human Trial

TC BioPharm Announces Dr. Sebastian Wanless as Senior Clinical Director

TC BioPharm Named as Top 5 Female Powered Companies in United Kingdom

2019

TC BioPharm opens offices in London and Leiden

TC BioPharm initiates Phase I trial of allogeneic gamma delta T cell therapy in Acute Myeloid Leukemia patients

Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director

TC BioPharm Extends Space at Maxim Park

Immunotherapy Company TC BioPharm partners with Trinity College Dublin to develop V delta 1 γδ T cell-based cancer treatments

TC BioPharm creates allogeneic cell banks for CAR-T cancer therapy products

2018

TCB wins High Growth Company of the Year at Scotland's Life Science Awards

TC BioPharm Broadens CAR-T Drug Pipeline

TC BioPharm wins Life Sciences Company of the Year 2018

Scottish Immunotherapy Company Opens First Overseas Office in Japan

TC BioPharm and the NIPRO Corporation Announce Strategic Programme Co-Developing a Novel Gamma-Delta CAR-T Product to Treat Cancer

2017

TC Biopharm Announces Strategic Collaboration with bluebird bio

TC BioPharm Announces CAR-T Licensing Deal With UCL Business

TCB Selected For EU Horizon 2020 Funding to Progress Novel, Mass-Market Cell Therapies to Clinical Trial

Scottish immunotherapy company raises over £6m for innovative cancer treatments

2015

TC BioPharm starts clinical study in cancer patients

TC BioPharm granted approval to treat cancer patients

Investing Women appoint director to TC BioPharm board

TC BioPharm Ltd raises £1.2m to commence treatment of UK cancer patients

TC BioPharm gets green light for cancer trial